Vivanza Biosciences Past Earnings Performance
Past criteria checks 2/6
Vivanza Biosciences has been growing earnings at an average annual rate of 57.5%, while the Healthcare industry saw earnings growing at 30% annually. Revenues have been growing at an average rate of 37.6% per year. Vivanza Biosciences's return on equity is 11.8%, and it has net margins of 2%.
Key information
57.5%
Earnings growth rate
56.3%
EPS growth rate
| Healthcare Industry Growth | 29.4% |
| Revenue growth rate | 37.6% |
| Return on equity | 11.8% |
| Net Margin | 2.0% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Vivanza Biosciences makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 279 | 5 | 5 | 0 |
| 31 Dec 23 | 317 | 9 | 5 | 0 |
| 30 Sep 23 | 310 | 11 | 4 | 0 |
| 30 Jun 23 | 250 | 10 | 4 | 0 |
| 31 Mar 23 | 182 | 6 | 4 | 0 |
| 31 Dec 22 | 160 | 5 | 4 | 0 |
| 30 Sep 22 | 114 | 0 | 4 | 0 |
| 30 Jun 22 | 129 | 1 | 4 | 0 |
| 31 Mar 22 | 112 | 3 | 3 | 0 |
| 31 Dec 21 | 112 | 5 | 4 | 0 |
| 30 Sep 21 | 105 | 6 | 3 | 0 |
| 30 Jun 21 | 99 | 6 | 3 | 0 |
| 31 Mar 21 | 99 | 1 | 3 | 0 |
| 31 Dec 20 | 130 | 7 | 4 | 0 |
| 30 Sep 20 | 120 | 4 | 4 | 0 |
| 30 Jun 20 | 98 | -2 | 3 | 0 |
| 31 Mar 20 | 96 | -2 | 3 | 0 |
| 31 Dec 19 | 50 | -8 | 3 | 0 |
| 30 Sep 19 | 19 | -9 | 3 | 0 |
| 30 Jun 19 | 21 | -8 | 2 | 0 |
| 31 Mar 19 | 27 | -4 | 2 | 0 |
| 31 Dec 18 | 25 | -2 | 1 | 0 |
| 30 Sep 18 | 45 | 1 | 0 | 0 |
| 30 Jun 18 | 48 | 2 | 0 | 0 |
| 31 Mar 18 | 64 | 2 | 1 | 0 |
| 31 Dec 17 | 77 | 3 | 2 | 0 |
| 30 Sep 17 | 62 | 0 | 3 | 0 |
| 30 Jun 17 | 61 | -1 | 4 | 0 |
| 31 Mar 17 | 35 | -3 | 4 | 0 |
| 31 Dec 16 | 9 | -5 | 4 | 0 |
| 30 Sep 16 | 5 | -3 | 3 | 0 |
| 30 Jun 16 | 0 | -2 | 1 | 0 |
| 31 Mar 16 | 0 | -1 | 0 | 0 |
| 31 Dec 15 | 0 | -1 | 0 | 0 |
| 30 Sep 15 | 0 | -1 | 0 | 0 |
| 30 Jun 15 | 0 | -1 | 0 | 0 |
| 31 Mar 15 | 0 | -1 | 0 | 0 |
| 31 Dec 14 | 0 | -1 | 0 | 0 |
| 30 Sep 14 | 0 | -1 | 0 | 0 |
| 30 Jun 14 | 0 | -1 | 0 | 0 |
| 31 Mar 14 | 0 | -1 | 0 | 0 |
| 31 Dec 13 | 0 | -6 | 0 | 0 |
Quality Earnings: 530057 has high quality earnings.
Growing Profit Margin: 530057's current net profit margins (2%) are lower than last year (3.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 530057 has become profitable over the past 5 years, growing earnings by 57.5% per year.
Accelerating Growth: 530057's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 530057 had negative earnings growth (-8.5%) over the past year, making it difficult to compare to the Healthcare industry average (25%).
Return on Equity
High ROE: 530057's Return on Equity (11.8%) is considered low.